Mostrar el registro sencillo del documento
Molecular diagnostic technologies for COVID-19: Limitations and challenges
dc.creator | Afzal, Adeel | |
dc.date.accessioned | 2020-08-12T15:52:14Z | |
dc.date.available | 2020-08-12T15:52:14Z | |
dc.date.created | 2020 | |
dc.identifier.issn | 2090-1232 | spa |
dc.identifier.other | https://doi.org/10.1016/j.jare.2020.08.002 | spa |
dc.identifier.uri | http://hdl.handle.net/20.500.12010/11870 | |
dc.description.abstract | To curb the spread of COVID-19 (coronavirus disease 2019) pandemic, the world needs diagnostic systems capable of rapid detection and quantification of the novel coronavirus (SARS-CoV-2). Many biomedical companies are rising to the challenge and developing COVID-19 diagnostics. In the last few months, some of these diagnostics have become commercially available for healthcare workers and clinical laboratories. However, the diagnostic technologies have specific limitations and reported several false-positive and false-negative cases, especially during the early stages of infection. Currently, more sophisticated and reliable molecular diagnostics are being developed to improve the COVID-19 diagnosis. This article presents an overview of the commercial and pre-commercial molecular diagnostics to address several questions and issues related to the limitations of current technologies and future research and development challenges to enable timely, rapid, low-cost, and accurate diagnosis of emerging infectious diseases. | spa |
dc.format.extent | 31 páginas | spa |
dc.format.mimetype | image/jepg | spa |
dc.publisher | Journal of Advanced Research | spa |
dc.source | reponame:Expeditio Repositorio Institucional UJTL | spa |
dc.source | instname:Universidad de Bogotá Jorge Tadeo Lozano | spa |
dc.subject | COVID-19 | spa |
dc.subject | Clinical sensitivity | spa |
dc.subject | In vitro diagnostics | spa |
dc.subject | Real-time RT-PCR | spa |
dc.subject | Point-of-care | spa |
dc.subject | SARS-CoV-2 | spa |
dc.title | Molecular diagnostic technologies for COVID-19: Limitations and challenges | spa |
dc.type.local | Artículo | spa |
dc.subject.lemb | Síndrome respiratorio agudo grave | spa |
dc.subject.lemb | COVID-19 | spa |
dc.subject.lemb | SARS-CoV-2 | spa |
dc.subject.lemb | Coronavirus | spa |
dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
dc.type.hasversion | info:eu-repo/semantics/acceptedVersion | spa |
dc.rights.local | Abierto (Texto Completo) | spa |
dc.identifier.doi | https://doi.org/10.1016/j.jare.2020.08.002 | spa |